Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Needham Reiterates Buy on RxSight, Maintains $22 Price Target

Needham analyst David Saxon reiterates RxSight (NASDAQ:RXST) with a Buy and maintains $22 price target.

byBenzinga Newsdesk

March 7, 2023

1 minute read

Needham analyst David Saxon reiterates RxSight (NASDAQ:RXST) with a Buy and maintains $22 price target.

Shinzo Abe’s Alleged Killer Honed His Gunmaking Skills On YouTube, Tested Weapon At Religious Facility

By Shivdeep Dhaliwal

July 11, 3:56 AM

The man who allegedly shot dead former Prime Minister of Japan, Shinzo Abe, learned to make guns by watching videos on Alphabet Inc's (NASDAQ: GOOGL) (NASDAQ: GOOG) Youtube and

GOOG

AMMO Reiterates FY23 Guidance

By Benzinga Newsdesk

August 15, 4:06 PM

Reiterating Fiscal Year 2023 Guidance Total Revenues of $300 million to $310 million EBITDA of $82 million to $85 million Adjusted EBITDA of $108

POWW

Bitcoin, Ethereum Subdued, Dogecoin Emerges As Top Gainer: What’s Putting Pressure On Apex Coin?

By Shivdeep Dhaliwal

April 5, 9:32 PM

Bitcoin and Ethereum declined Tuesday evening, while Dogecoin emerged as the top intraday gainer, as the global cryptocurrency market cap fell 3% to $2.1 trillion.

$DOGE